News Agency
The Times

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

  • Written by PR Newswire
  • Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol)
  • Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care's commercial platform to grow Movantik volume in the U.S. while reducing gross-to-net and operating costs
  • First quarter financial highlights...

Read more: Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion